Spero Therapeutics
Price & Volume
Stats
See more52W Range | $0.50-$3.22 |
Market Cap | $133.5M |
Shares Short | 537,411 |
Financials
See moreRevenue (12 Mos) | $40.5M |
Revenue Growth (YoY) | -59.6% |
Gross Profit (12 Mos) | -$21.1M |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • 19 hours ago
Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M
Yahoo Finance • 9 days ago
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
Yahoo Finance • 2 months ago
Airgain And 2 Other Promising Penny Stocks
Yahoo Finance • 4 months ago
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Ms. Esther P. Rajavelu |
Address | 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
